ES462060A1 - Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.

Info

Publication number
ES462060A1
ES462060A1 ES462060A ES462060A ES462060A1 ES 462060 A1 ES462060 A1 ES 462060A1 ES 462060 A ES462060 A ES 462060A ES 462060 A ES462060 A ES 462060A ES 462060 A1 ES462060 A1 ES 462060A1
Authority
ES
Spain
Prior art keywords
alkyl
group
tetrahydroisoquinoline
pharmaceutical compositions
methods employing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES462060A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES462060A1 publication Critical patent/ES462060A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Un Un procedimiento para la preparación de nuevos derivados de tetrahidroisoquinoleina de fórmula II ***(Ver fórmula I) y sales del mismo, donde R1 es un grupo alquilo C1-6, ciclo alquilo C3-6, fenilo, naftilo, aralquilo, fenilo sustituido o naftilo sustituido; R2 es un grupo ***(Ver fórmula II) donde R6 es un átomo de hidrógeno o un grupo alquilo C1-6, R7 es un átomo de hidrógeno o un grupo alquilo C1-6, fenilo tolilo o bencilo o bien R6 está unido a R7 de manera que el radical NR6R7 es un anillo de r5 6 o 7 miembros, R8 es un átomo de hidrógeno o un grupo alquilo C1-4.
ES462060A 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina. Expired ES462060A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33283/75A GB1504424A (en) 1975-08-09 1975-08-09 Isoquinoline-derived aminoethers

Publications (1)

Publication Number Publication Date
ES462060A1 true ES462060A1 (es) 1978-06-16

Family

ID=10350917

Family Applications (6)

Application Number Title Priority Date Filing Date
ES450550A Expired ES450550A1 (es) 1975-08-09 1976-08-06 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462059A Expired ES462059A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462058A Expired ES462058A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462061A Expired ES462061A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES77462062A Expired ES462062A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462060A Expired ES462060A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.

Family Applications Before (5)

Application Number Title Priority Date Filing Date
ES450550A Expired ES450550A1 (es) 1975-08-09 1976-08-06 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462059A Expired ES462059A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462058A Expired ES462058A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES462061A Expired ES462061A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES77462062A Expired ES462062A1 (es) 1975-08-09 1977-09-01 Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.

Country Status (19)

Country Link
US (1) US4113869A (es)
JP (1) JPS5223083A (es)
AT (2) AT354448B (es)
AU (1) AU498422B2 (es)
BE (1) BE844783A (es)
CA (1) CA1076119A (es)
CH (2) CH622780A5 (es)
DE (1) DE2635276A1 (es)
DK (1) DK357976A (es)
ES (6) ES450550A1 (es)
FR (1) FR2320755A1 (es)
GB (1) GB1504424A (es)
HU (1) HU173560B (es)
IE (1) IE43506B1 (es)
IL (1) IL50176A (es)
NL (1) NL7608856A (es)
NZ (1) NZ181619A (es)
SE (1) SE7608641L (es)
ZA (1) ZA764555B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4340600A (en) 1980-05-22 1982-07-20 Smithkline Corporation Renal dilating methods and compositions using 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
US4375471A (en) * 1981-02-19 1983-03-01 Hoechst-Roussel Pharmaceuticals Inc. 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines
US4551474A (en) * 1981-02-19 1985-11-05 Hoechst-Roussel Pharmaceuticals Incorporated Methods of alleviating convulsions and pain employing 4-aryloxy-1,2,3,4 tetrahydroisoquinolines
US4477670A (en) * 1981-02-19 1984-10-16 Hoechst-Roussel Pharmaceuticals Inc. 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines
US6562837B1 (en) * 1998-10-21 2003-05-13 Korea Institute Of Science & Technology Use of tetrahydroisoquinoline compounds for the treatment of septicemia
NZ519146A (en) * 1999-11-03 2004-02-27 Albany Molecular Res Inc 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
WO2001032625A1 (en) * 1999-11-03 2001-05-10 Du Pont Pharmaceuticals Company Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
EP1113007A1 (en) * 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
JP5132864B2 (ja) 2000-07-11 2013-01-30 アルバニー モレキュラー リサーチ， インコーポレイテッド ４−フェニル置換テトラヒドロイソキノリンおよびその使用方法
US7314937B2 (en) * 2002-03-21 2008-01-01 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
AU2005274927B2 (en) 2004-07-15 2011-11-03 Albany Molecular Research, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US20060111385A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
US20060111393A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US20060111394A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
DE602005026169D1 (de) * 2004-12-17 2011-03-10 Janssen Pharmaceutica Nv Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
DE602006002894D1 (de) 2005-06-17 2008-11-06 Janssen Pharmaceutica Nv Naphthyridinverbindungen
CA2612495A1 (en) * 2005-06-17 2006-12-28 Janssen Pharmaceutica N.V. Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders
KR101594898B1 (ko) 2005-07-15 2016-02-18 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
US7846930B2 (en) * 2007-05-18 2010-12-07 Janssen Pharmaceutica Nv Diaryl-substituted tetrahydroisoquinolines as histamine H3 receptor and serotonin transporter modulators
AR071997A1 (es) * 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
WO2010132487A1 (en) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
US8802696B2 (en) 2009-05-12 2014-08-12 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof
CN102458123A (zh) * 2009-05-12 2012-05-16 阿尔巴尼分子研究公司 芳基、杂芳基和杂环取代的四氢异喹啉及其用途
EP2451461A4 (en) 2009-07-06 2013-05-29 Ontorii Inc NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
DK2620428T3 (da) * 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
CN112007045B (zh) 2012-07-13 2026-01-06 波涛生命科学有限公司 手性控制
JP6246121B2 (ja) 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
EP3095461A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
US3479358A (en) * 1966-09-19 1969-11-18 Warner Lambert Pharmaceutical Hexahydro-9,4a - iminoethano-4a-h-xanthenes and process for their production
US3947456A (en) * 1970-01-06 1976-03-30 Hoffman-La Roche Inc. Substituted 4-phenyl isoquinolines
US3666763A (en) * 1970-01-06 1972-05-30 Hoffmann La Roche 4-phenyl isoquinolines and process for preparing same
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
US3910924A (en) * 1972-04-13 1975-10-07 Otsuka Pharma Co Ltd 3,4-Dihydrocarbostyril derivatives and a process for preparing the same
US3855227A (en) * 1972-05-08 1974-12-17 C Hollander ({31 )-di-o-isopropylidene-2-keto-l-gulonates
JPS5239035B2 (es) * 1972-12-14 1977-10-03
US3872125A (en) * 1973-03-03 1975-03-18 Sandoz Ag 3-substituted-4-aryl isoquinolines
US3870722A (en) * 1973-11-02 1975-03-11 Sandoz Ag 2-Methyl-3-substituted-4-aryl isoquinolines
AR206061A1 (es) * 1974-11-15 1976-06-23 Knoll Ag Procedimiento para la produccion de nuevas 2-alcanoil (c1-c4)-1, 2, 3, 4-tetrahidro-8-respectivamente 7-, 6- o 5-(2-hidroxi-3-alquil (c3-c4)-aminopropoxi)-isoquinolinas de 2-alcanoil (c1-c4)-1, 2, 3, 4-tetrahidro-8-respectivamente 7- o 5-(2-hidroxi-3-alquil (c3-c4)-aminopropoxi)-6-metoxi-isoquinolinas y de 2-alcanoil (c1-c4)-1, 2, 3, 4-tetrahidro-8-respectivamente 6- o 5-(2-hidroxi-3-alquil (c3-c4)-aminopropoxi)-7-metoxi-isoquinolinas eventualmente metiladas en la posicion 1

Also Published As

Publication number Publication date
ES462058A1 (es) 1978-06-16
ZA764555B (en) 1977-07-27
IL50176A0 (en) 1976-09-30
AU1670276A (en) 1978-02-16
SE7608641L (sv) 1977-02-10
DK357976A (da) 1977-02-10
ES462059A1 (es) 1978-06-16
NZ181619A (en) 1979-08-31
IE43506L (en) 1977-02-09
CA1076119A (en) 1980-04-22
IE43506B1 (en) 1981-03-11
ATA586876A (de) 1979-06-15
ES462061A1 (es) 1978-06-16
AU498422B2 (en) 1979-03-15
ATA717378A (de) 1979-05-15
ES462062A1 (es) 1978-06-16
CH622780A5 (es) 1981-04-30
JPS5223083A (en) 1977-02-21
US4113869A (en) 1978-09-12
CH626611A5 (es) 1981-11-30
AT353793B (de) 1979-12-10
DE2635276A1 (de) 1977-02-17
FR2320755A1 (fr) 1977-03-11
AT354448B (de) 1979-01-10
NL7608856A (nl) 1977-02-11
GB1504424A (en) 1978-03-22
FR2320755B1 (es) 1979-09-14
HU173560B (hu) 1979-06-28
ES450550A1 (es) 1977-12-16
BE844783A (fr) 1977-01-31
IL50176A (en) 1979-10-31

Similar Documents

Publication Publication Date Title
ES462062A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
BG33585A3 (bg) Нов метод за получаване на азини
FR2325619A1 (fr) Composition refractaire a mettre en place par projection
ES396134A1 (es) Procedimiento para la preparacion de derivados de 1,1,1- tricloroetano.
JPS52264A (en) Process for preparing novel isoxazole derivatives
ES483253A1 (es) Un procedimiento para la prepracion de derivados de pipera- zin-2,5-diona.
ES444036A1 (es) Procedimiento de preparacion de la (tienil-2)-2-etilamina y sus derivados.
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
SE7608119L (sv) Polycykliska foreningar
ES396175A1 (es) Procedimiento para la preparacion de compuestos derivados de aminoetanol.
ATE25661T1 (de) Aphidicolanderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES364980A1 (es) Un metodo para preparar nuevos derivados de adamantano.
ES461191A1 (es) Un procedimiento para la preparacion de nuevos derivados de arilcarboxamida.
ES393340A1 (es) Procedimiento para la preparacion de derivados de bornanami-na.
BG34184A3 (bg) Метод за получаване на заместен пиролидинилметил-3-аминокротонат
ES325366A1 (es) Procedimiento para la produccion de derivados de la isoquinolina.
ES413743A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
ES438056A3 (es) Procedimiento para la preparacion de nuevos derivados de a- cidos carboxilicos ciclicos.
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.
ES461637A1 (es) Un procedimiento para la preparacion de compuestos tiazoli- nil cetobenzimidazoles.
ES405281A1 (es) Un procedimiento para preparar nuevos compuestos de cefa- losporina.
ES231946A2 (es) MEJORAS INTRODUCIDAS EN LA PREPARACIoN DE COMPOSICIONES TERAPÉUTICAS
ES428624A1 (es) Procedimiento para la preparacion de derivados de la pirimi-dina.
ES240162A1 (es) PROCEDIMIENTO DE FABRICACIoN DE NUEVOS DERIVADOS DE QUINOLONA
ES324844A1 (es) Material diazotipia.